agree with all the thinking to date.
IMO Jon and NEU are looking to do a few things for maximum value:
First as priority - prove NNZ for PhIII for a few select conditions;
Secondly, in parallel to the first objective - prove NNZ COULD be applied to multiple conditions, including Autism;
Lastly - end game - either partner or be acquired to see the true potential of NNZ
IMO Neurens main focus has to be PhIII - not Daybue revenue, share buybacks, dividends or any other frivolous stuff.
To date they have in my mind proven the POSSIBILITY of the 2nd objective (ie multiple conditions). Thats the LT carrot for any potential buyer.
Immediately, they now need to be seen as getting on with PhIII to really up the ante !
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11177
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.94 |
Change
0.000(0.00%) |
Mkt cap ! $2.037B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 660 | $16.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.62 | 144 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 660 | 16.750 |
12 | 4424 | 16.730 |
3 | 2942 | 16.720 |
1 | 870 | 16.700 |
3 | 1629 | 16.680 |
Price($) | Vol. | No. |
---|---|---|
14.620 | 144 | 1 |
15.160 | 2571 | 3 |
15.390 | 5 | 1 |
15.420 | 27 | 2 |
15.430 | 33 | 1 |
Last trade - 10.00am 14/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online